李燕青;简凤璧;谭俊;
LI Yanqing;JIAN Fengbi;TAN Jun;Department of Pharmacy,Guangzhou Eighth People's Hospital;

• 1:广州市第八人民医院药剂科

摘要(Abstract)：

目的分析艾滋病患者抗病毒治疗后CD_4~+T淋巴细胞及血液生化指标的变化情况。方法选取2018年1～6月正在进行高效抗逆转录病毒治疗(HAART,方案为:齐多夫定或替诺福韦+拉米夫定+依非韦伦)的艾滋病患者131例,通过回顾性分析收集其治疗前后的CD_4~+T淋巴细胞及丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、肌酐(Cr)、白细胞(WBC)、中性粒细胞百分比(NEU%)、红细胞(RBC)、血小板(PLT)、总胆固醇(TC)和甘油三酯(TG)等血液检测结果并进行统计分析。结果经过1年以上的治疗,艾滋病患者CD_4~+T淋巴细胞与治疗前相比有显著升高(P<0.01),治疗后ALT、Cr、WBC、PLT、TC和TG都高于基线水平,差异有统计学意义(P<0.05)。结论 HAART能有效提高艾滋病患者的免疫功能,实现免疫重建,但需要加强对肝肾功能、血常规及血脂水平的检测。
OBJECTIVE To analyze the changes of CD_4~+ T lymphocytes and blood biochemical indexes in AIDS patients after HAART treatment. METHODS 131 cases of AIDS patients taking HAART treatment( regimen: AZT/TDF+3 TC+EFV) from January to June of 2018 were selected,whose CD_4~+ T lymphocytes and alanine aminotransferase( ALT),aspartate aminotransferase( AST),creatinine( Cr),white blood cells( WBC),neutrophil percentage( NEU%),red blood cell( RBC),platelet( PLT),total cholesterol( TC) and triglyceride( TG) before and after treatment were collected retrospectively and analyzed statistically. RESULTS After more than one year of treatment,CD_4~+ T lymphocytes of AIDS patients increased significantly compared to baseline( P<0.01). ALT,Cr,WBC,PLT,TC and TG were all higher than the baseline after treatment,with statistically significant differences( P < 0.05).CONCLUSION HAART can effectively improve the immune function of AIDS patients and achieve immune reconstruction,but it is necessary to strengthen the detection of liver and kidney function,blood routine and lipid level.

关键词(KeyWords)： 艾滋病;高效抗逆转录病毒治疗;CD_4~+T淋巴细胞;血液生化指标
AIDS;HAART;CD_4~+T lymphocytes;blood biochemical index

Abstract:

Keywords:

基金项目(Foundation): 广州市卫生和计划生育科技项目(20181A010032)

作者(Author): 李燕青;简凤璧;谭俊;
LI Yanqing;JIAN Fengbi;TAN Jun;Department of Pharmacy,Guangzhou Eighth People's Hospital;

Email:

DOI:

参考文献(References)：

• [1]中华医学会感染病学分会艾滋病丙型肝炎学组，中国疾病预防控制中心．中国艾滋病诊疗指南(2018版)[J]．中国艾滋病性病，2018(12):1266-1282.
• [2]李太生．中国艾滋病抗病毒治疗十五年:成功与挑战[J]．四川医学，2018,39(9):987-989.
• [3]余学如，罗娅薇，余小辉．某医院艾滋病患者抗病毒治疗中的不良反应分析[J]．今日药学，2018,28(10):705-707.
• [4]He L,Pan X H,Dou Z H,et al. The Factors Related to CD4+T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+T Cell Counts at the Initiation of HAART:A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province,China,2014[J].PLoS ONE,11(2):e0148915.
• [5]陈淑娟．山西省介休市HIV/AIDS患者抗病毒治疗效果评价[J]．中国社区医师，2018,34(28):12-15.
• [6]谈洁，丁陈丽，陈娟，等．常进市武进区2006-2017年HIV/AIDS病人抗病毒治疗效果评价[J]．江苏预防医学，2018,29(5):494-496.
• [7]Lebrun D,Hentzien M,Cuzin L,et al. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort[J].AIDS,2017,31(15):2159-2166.
• [8]Worm S W,De W S,Weber R,et al. Diabetes mellitus,preexisting coronary heart disease,and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus:the data collection on adverse eventsof Anti-HIV drugs(D:A:D Study)[J].Circulation,2009,119(6):805-811.
• [9]中国疾病预防控制中心性病艾滋病预防控制中心．国家免费艾滋病抗病毒药物治疗手册[M]．第4版．北京:人民卫生出版社，2016:144.
• [10]Mira J A,Pineda J A,Rivero A. Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors[J].J Antimicrob Chemother,2007,59(3):342-346.
• [11]Sinxadi P Z,Mc Illeron H M,Dave J A,et al. Plasma Efavirenz Concentrations Are Associated With Lipid and Glucose Concentrations[J].Medicine(Baltimore),2016,95(2):e2385.
• [12]赵方，李巍，郑祎，等．艾滋病抗病毒治疗患者依非韦伦血药浓度及相关因素的分析[J]．新发传染病电子杂志，2019,4(2):103-107.
• [13]夏玉朝，杨萱，陈岩岩，等．替诺福韦治疗获得性免疫缺陷综合征导致肾损伤98例回顾性分析[J]．中国新药与临床杂志，2018,37(12):721-724.
• [14]卢美玲，杨晴．替诺福韦酯肾损害的研究进展[J]．中国当代医药，2018,25(16):32-35.
• [15]Mizushima D,Tanuma J,Kanaya F,et al. WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV infected patients[J]. PLoS One,2013,8(11):e79885.
• [16]乐晓琴，张仁芳．富马酸替诺福韦二吡呋酯对艾滋病患者肾脏毒性的研究进展[J]．新发传染病电子杂志，2018,3(3):150-152.
• [17]陈绛青，朱冬红，胡塔，等．含替诺福韦抗艾滋病毒治疗对HIV/AIDS病人的肾功能影响[J]．江西医药，2018,53(8):779-783.
• [18]张美，张红，李旺泉，等．艾滋病免费抗病毒治疗长期疗效和血常规变化[J]．中华临床医师杂志(电子版)，2017,11(3):413-416.
• [19]向信春，丁芳，李佳豫．8例艾滋病患者进行依非韦伦、拉米夫定和替诺福韦治疗的生化指标分析[J]．中国医药指南，2015,13(12):157-158.
• [20] Rodríguez A J,Neeman T,Giles A G,et al. Leptin replacement therapy for the treatment of non-HAART associated lipodystrophy syndromes:a meta-analysis into the effects of leptin on metabolic and hepatic endpoints[J]. Arq Bras Endocrinol Metabol,2014,58(8):783-797.